IBM shares tank despite upbeat Q1 earnings. Analysts maintain Buy rating and $270 price target. Stock decline appears overdone.
Latest Ratings for IBM
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2022 | BMO Capital | Maintains | Market Perform | |
| Jan 2022 | UBS | Downgrades | Neutral | Sell |
| Jan 2022 | Goldman Sachs | Initiates Coverage On | Neutral |
